Promoter hypomethylation is at the basis of the up-regulation of galectin-7 during lymphoma progression [123], while promoter hypermethylation is responsible for galectin-7 downregulation in gastric cancer, a tumor in which it has a tumor suppressive function [124]. The gene discussed is LGALS7; the disease is neoplasm.